Lentiviral based gene transduction and promoter studies in human hematopoietic stem cells (hHSCs)

Journal of Stem Cells and Regenerative Medicine

Volumn 7, Issue 1, 2011, Pages 41-53

  Varma, Nadimpalli Ravi S ^a   Janic, Branislava ^a   Ali, M Meser ^a   Iskander, A S M ^a   Arbab, Ali S ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Cord blood stem cells (AC133+); Lentiviral vectors; Promoters and green fluorescent protein (GFP)

Indexed keywords

CD133 ANTIGEN; ELONGATION FACTOR 1ALPHA; GREEN FLUORESCENT PROTEIN; GROWTH FACTOR; LENTIVIRUS VECTOR; UBIQUITIN C;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CORD BLOOD STEM CELL; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; PROMOTER REGION; REPORTER GENE; SIMIAN VIRUS 40; STEM CELL; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

HUMAN HERPESVIRUS 5; LENTIVIRUS; MAMMALIA; SIMIAN VIRUS 40;

EID: 80052072422     PISSN: 09737154     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Fibbe WE, Noort WA, Schipper F, Willemze R: Ex vivo expansion and engraftment potential of cord blood-derived CD34+ cells in NOD/SCID mice. Ann N Y Acad Sci 2001, 938:9-17.
2. Hao QL, Shah AJ, Thiemann FT, Smogorzewska EM, Crooks GM: A functional comparison of CD34 + CD38- cells in cord blood and bone marrow. Blood 1995, 86:3745-3753.
3. Aker M, Varadi G, Slavin S, Nagler A: Fludarabine-based protocol for human umbilical cord blood transplantation in children with Fanconi anemia. J Pediatr Hematol Oncol 1999, 21:237-239.
4. Bielorai B, Hughes MR, Auerbach AD, Nagler A, Loewenthal R, Rechavi G, Toren A: Successful umbilical cord blood transplantation for Fanconi anemia using preimplantation genetic diagnosis for HLA-matched donor. Am J Hematol 2004, 77:397-399.
5. Kohn DB: Gene therapy for haematopoietic and lymphoid disorders. Clin Exp Immunol 1997, 107 Suppl 1:54-57.
6. Richter J: Gene transfer to hematopoietic cells--the clinical experience. Eur J Haematol 1997, 59:67-75.
7. Miller DG, Adam MA, Miller AD: Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990, 10:4239-4242.
8. Lewis PF, Emerman M: Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 1994, 68:510-516.
9. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D: In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996, 272:263-267.
10. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D: Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 1997, 15:871-875.
11. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L: A third-generation lentivirus vector with a conditional packaging system. J Virol 1998, 72:8463-8471.
12. Akkina RK, Walton RM, Chen ML, Li QX, Planelles V, Chen IS: High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J Virol 1996, 70:2581-2585.
13. Reiser J, Harmison G, Kluepfel-Stahl S, Brady RO, Karlsson S, Schubert M: Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc Natl Acad Sci U S A 1996, 93:15266-15271.
14. Najjar SM, Lewis RE: Persistent expression of foreign genes in cultured hepatocytes: expression vectors. Gene 1999, 230:41-45.
15. Ramezani A, Hawley TS, Hawley RG: Lentiviral vectors for enhanced gene expression in human hematopoietic cells. Mol Ther 2000, 2:458-469.
16. Keating A, Horsfall W, Hawley RG, Toneguzzo F: Effect of different promoters on expression of genes introduced into hematopoietic and marrow stromal cells by electroporation. Exp Hematol 1990, 18:99-102.
17. Muller SR, Sullivan PD, Clegg DO, Feinstein SC: Efficient transfection and expression of heterologous genes in PC12 cells. DNA Cell Biol 1990, 9:221-229.
18. Tokushige K, Moradpour D, Wakita T, Geissler M, Hayashi N, Wands JR: Comparison between cytomegalovirus promoter and elongation factor-1 alpha promoter-driven constructs in the establishment of cell lines expressing hepatitis C virus core protein. J Virol Methods 1997, 64:73-80.
19. Nakai H, Herzog RW, Hagstrom JN, Walter J, Kung SH, Yang EY, Tai SJ, Iwaki Y, Kurtzman GJ, Fisher KJ, et al: Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver. Blood 1998, 91:4600-4607.
20. Teschendorf C, Warrington KH, Jr., Siemann DW, Muzyczka N: Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus. Anticancer Res 2002, 22:3325-3330.
21. Marinovic AC, Mitch WE, Price SR: Tools for evaluating ubiquitin (UbC) gene expression: characterization of the rat UbC promoter and use of an unique 3' mRNA sequence. Biochem Biophys Res Commun 2000, 274:537-541.
22. Gill DR, Smyth SE, Goddard CA, Pringle IA, Higgins CF, Colledge WH, Hyde SC: Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter. Gene Ther 2001, 8:1539-1546.
23. Yew NS, Przybylska M, Ziegler RJ, Liu D, Cheng SH: High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter. Mol Ther 2001, 4:75-82.
24. Selden C, Mellor N, Rees M, Laurson J, Kirwan M, Escors D, Collins M, Hodgson H: Growth factors improve gene expression after lentiviral transduction in human adult and fetal hepatocytes. J Gene Med 2007, 9:67-76.
25. Bank A: Hematopoietic stem cell gene therapy: selecting only the best. J Clin Invest 2003, 112:1478-1480.
26. Kohn DB, Sadelain M, Dunbar C, Bodine D, Kiem HP, Candotti F, Tisdale J, Riviere I, Blau CA, Richard RE, et al: American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells. Mol Ther 2003, 8:180-187.
27. Rad AM, Iskander AS, Janic B, Knight RA, Arbab AS, Soltanian-Zadeh H: AC133+ progenitor cells as gene delivery vehicle and cellular probe in subcutaneous tumor models: a preliminary study. BMC Biotechnol 2009, 9:28.
28. Barrette S, Douglas JL, Seidel NE, Bodine DM: Lentivirus-based vectors transduce mouse hematopoietic stem cells with similar efficiency to moloney murine leukemia virus-based vectors. Blood 2000, 96:3385-3391.
29. Blomer U, Naldini L, Kafri T, Trono D, Verma IM, Gage FH: Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J Virol 1997, 71:6641-6649.
30. Liu H, Hung Y, Wissink SD, Verfaillie CM: Improved retroviral transduction of hematopoietic progenitors by combining methods to enhance virus-cell interaction. Leukemia 2000, 14:307-311.
31. Schmidt M, Hacein-Bey-Abina S, Wissler M, Carlier F, Lim A, Prinz C, Glimm H, Andre-Schmutz I, Hue C, Garrigue A, et al: Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial. Blood 2005, 105:2699-2706.
32. Liu JW, Pernod G, Dunoyer-Geindre S, Fish RJ, Yang H, Bounameaux H, Kruithof EK: Promoter dependence of transgene expression by lentivirus-transduced human blood-derived endothelial progenitor cells. Stem Cells 2006, 24:199-208.
33. Persons DA, Allay JA, Allay ER, Smeyne RJ, Ashmun RA, Sorrentino BP, Nienhuis AW: Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood 1997, 90:1777-1786.
34. Bierhuizen MF, Westerman Y, Visser TP, Dimjati W, Wognum AW, Wagemaker G: Enhanced green fluorescent protein as selectable marker of retroviral-mediated gene transfer in immature hematopoietic bone marrow cells. Blood 1997, 90:3304-3315.
35. Karlsson S: Treatment of genetic defects in hematopoietic cell function by gene transfer. Blood 1991, 78:2481-2492.
36. Chu P, Lutzko C, Stewart AK, Dube ID: Retrovirus-mediated gene transfer into human hematopoietic stem cells. J Mol Med 1998, 76:184-192.
37. Kohn DB, Hershfield MS, Carbonaro D, Shigeoka A, Brooks J, Smogorzewska EM, Barsky LW, Chan R, Burotto F, Annett G, et al: T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates. Nat Med 1998, 4:775-780.
38. Riddell SR, Elliott M, Lewinsohn DA, Gilbert MJ, Wilson L, Manley SA, Lupton SD, Overell RW, Reynolds TC, Corey L, Greenberg PD: T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat Med 1996, 2:216-223.
39. Bonini C, Ferrari G, Verzeletti S, Servida P, Zappone E, Ruggieri L, Ponzoni M, Rossini S, Mavilio F, Traversari C, Bordignon C: HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 1997, 276:1719-1724.